Clinical trial · Interventional
Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer
A Multi-center Prospective Randomized Controlled Trial Comparing the Quality of Life Between Laparoscopic-assisted Distal Gastrectomy (LADG) and Totally Laparoscopic Distal Gastrectomy (TLDG) for Gastric Cancer
NCT05541783CI-TRIAL-00116296completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is comparing the short-term quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| laparoscopy-assisted distal gastrectomy Group | Procedure | — | UNRESOLVED |
| Totally laparoscopic distal gastrectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Laparoscopy-assisted distal gastrectomy
- description
- The patients who are assigned to LADG group undergo extracorporeal anasto- mosis for gastrointestinal reconstruction.
- interventionNames
- Procedure: laparoscopy-assisted distal gastrectomy Group
- type
- EXPERIMENTAL
- label
- Totally laparoscopic distal gastrectomy
- description
- The patients who are allocated to TLDG group undergo intracorporeal anastomosis for the recovery of gastrointes- tinal continuity after gastrectomy.
- interventionNames
- Procedure: Totally laparoscopic distal gastrectomy
Primary outcomes (1)
- measure
- Scores on the physical function and pain symptom scales of EORTC QLQ-C30 questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Aged 20-80 years; 2. Patients had an Eastern Cooperative Oncology Group performance status score of 0 or 1; 3. Patients had histologically confirmed gastric adenocarcinoma (tumor size\<5cm) at clinical stage I-III with T1-4aN0-2M0 excluding T4b or N3 tumors, according to the of the American Joint Committee on Cancer classification system, eighth edition; 4. Patients were expected to undergo laparoscopic distal gastrectomy with D2 lymphadenectomy. Exclusion Criteria: 1. Patients had bulky regional lymph nodes (larger than 3 cm at the long diameter) or possible distant metastasis in preoperative evaluation 2. Patients had history of chemotherapy, radiotherapy, immunotherapy or target therapy; 3. Patients had any concurrent or previous malignant tumor; 4. Patients had unstable cardiovascular, respiratory, kidney, or liver disease and poorly controlled hypertension, diabetes, mental disorders; history of upper abdominal surgery (except laparoscopic cholecystectomy). 5. Patients were histologically proven gastric adenocarcinoma (by preoperative gastrofiberscopy).
References
Publications (0)
Data not yet available
No reference posted for this study.